264 related articles for article (PubMed ID: 29512447)
1. Current Therapeutic Approaches for Targeting Inflammation in Depression and Cardiovascular Disease.
Zuzarte P; Duong A; Figueira ML; Costa-Vitali A; Scola G
Curr Drug Metab; 2018; 19(8):674-687. PubMed ID: 29512447
[TBL] [Abstract][Full Text] [Related]
2. Can Statins Diminish Depression?
Singh D; Lippmann S
Prim Care Companion CNS Disord; 2018 Jan; 20(1):. PubMed ID: 29372939
[TBL] [Abstract][Full Text] [Related]
3. Do Statins Have Antidepressant Effects?
Köhler-Forsberg O; Gasse C; Berk M; Østergaard SD
CNS Drugs; 2017 May; 31(5):335-343. PubMed ID: 28303466
[TBL] [Abstract][Full Text] [Related]
4. Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients.
Maes M; Ruckoanich P; Chang YS; Mahanonda N; Berk M
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):769-83. PubMed ID: 20561554
[TBL] [Abstract][Full Text] [Related]
5. [Similarities, differences and agonisms of pleiotropic effects of statins and omega-3 fatty acids].
Villalobos ME; Sánchez-Muniz FJ; Acín MT; Vaquero MP; Higueras FJ; Bastida S
Nutr Hosp; 2010; 25(6):889-909. PubMed ID: 21519759
[TBL] [Abstract][Full Text] [Related]
6. The Importance of the Structural Similarity of Drugs Used for Depression and Inflammation, Two Comorbid Diseases.
Bayram FEÖ; Reis R; Tunçer B; Sipahi H
Curr Top Med Chem; 2018; 18(16):1416-1421. PubMed ID: 30129414
[TBL] [Abstract][Full Text] [Related]
7. Immune-based strategies for mood disorders: facts and challenges.
Colpo GD; Leboyer M; Dantzer R; Trivedi MH; Teixeira AL
Expert Rev Neurother; 2018 Feb; 18(2):139-152. PubMed ID: 29179585
[TBL] [Abstract][Full Text] [Related]
8. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
Danesh FR; Kanwar YS
FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
[TBL] [Abstract][Full Text] [Related]
9. New drug candidates for depression - a nationwide population-based study.
Kessing LV; Rytgaard HC; Gerds TA; Berk M; Ekstrøm CT; Andersen PK
Acta Psychiatr Scand; 2019 Jan; 139(1):68-77. PubMed ID: 30182363
[TBL] [Abstract][Full Text] [Related]
10. Statins and polyunsaturated fatty acids for treatment of atrial fibrillation.
Savelieva I; Camm J
Nat Clin Pract Cardiovasc Med; 2008 Jan; 5(1):30-41. PubMed ID: 18094671
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory treatment and risk for depression after first-time stroke in a cohort of 147 487 Danish patients.
Wium-Andersen IK; Wium-Andersen MK; Jørgensen MB; Osler M
J Psychiatry Neurosci; 2017 Sep; 42(5):320-330. PubMed ID: 28632121
[TBL] [Abstract][Full Text] [Related]
12. Are Non-steroidal Anti-Inflammatory Drugs Clinically Suitable for the Treatment of Symptoms in Depression-Associated Inflammation?
Baune BT
Curr Top Behav Neurosci; 2017; 31():303-319. PubMed ID: 27405497
[TBL] [Abstract][Full Text] [Related]
13. The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.
Athyros VG; Alexandrides TK; Bilianou H; Cholongitas E; Doumas M; Ganotakis ES; Goudevenos J; Elisaf MS; Germanidis G; Giouleme O; Karagiannis A; Karvounis C; Katsiki N; Kotsis V; Kountouras J; Liberopoulos E; Pitsavos C; Polyzos S; Rallidis LS; Richter D; Tsapas AG; Tselepis AD; Tsioufis K; Tziomalos K; Tzotzas T; Vasiliadis TG; Vlachopoulos C; Mikhailidis DP; Mantzoros C
Metabolism; 2017 Jun; 71():17-32. PubMed ID: 28521870
[TBL] [Abstract][Full Text] [Related]
14. Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment.
Schmidt FM; Kirkby KC; Lichtblau N
Curr Neuropharmacol; 2016; 14(7):674-87. PubMed ID: 26769225
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic approaches to target inflammation in type 2 diabetes.
Goldfine AB; Fonseca V; Shoelson SE
Clin Chem; 2011 Feb; 57(2):162-7. PubMed ID: 21098138
[TBL] [Abstract][Full Text] [Related]
16. The Promise and Limitations of Anti-Inflammatory Agents for the Treatment of Major Depressive Disorder.
Raison CL
Curr Top Behav Neurosci; 2017; 31():287-302. PubMed ID: 27278642
[TBL] [Abstract][Full Text] [Related]
17. Do the pleiotropic effects of statins in the vasculature predict a role in inflammatory diseases?
McCarey DW; Sattar N; McInnes IB
Arthritis Res Ther; 2005; 7(2):55-61. PubMed ID: 15743490
[TBL] [Abstract][Full Text] [Related]
18. The role of macrophages in anti-inflammatory activity of antidepressant drugs.
Nazimek K; Strobel S; Bryniarski P; Kozlowski M; Filipczak-Bryniarska I; Bryniarski K
Immunobiology; 2017 Jun; 222(6):823-830. PubMed ID: 27453459
[TBL] [Abstract][Full Text] [Related]
19. Inflammation in Depression and the Potential for Anti-Inflammatory Treatment.
Kohler O; Krogh J; Mors O; Benros ME
Curr Neuropharmacol; 2016; 14(7):732-42. PubMed ID: 27640518
[TBL] [Abstract][Full Text] [Related]
20. Depression and cardiovascular sequelae in postmenopausal women. The Women's Health Initiative (WHI).
Wassertheil-Smoller S; Shumaker S; Ockene J; Talavera GA; Greenland P; Cochrane B; Robbins J; Aragaki A; Dunbar-Jacob J
Arch Intern Med; 2004 Feb; 164(3):289-98. PubMed ID: 14769624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
